Home
Who We Are
Why KCAS?
Leadership Team
Quality Assurance
Client Testimonials
What We Do
Services
Biopharmaceutical
Pharmaceutical
Biomarkers
Sample Kits
Assays
Compound Classes
Platforms
News & Events
Upcoming Events
News
Resources
Equipment List
Assay List
Posters & White Papers
Virtual Lab Manual
Info Sheets
Careers
Contact
Blog
Home
Who We Are
Why KCAS?
Leadership Team
Quality Assurance
Client Testimonials
What We Do
Services
Biopharmaceutical
Pharmaceutical
Biomarkers
Sample Kits
Assays
Compound Classes
Platforms
News & Events
Upcoming Events
News
Resources
Equipment List
Assay List
Posters & White Papers
Virtual Lab Manual
Info Sheets
Careers
Contact
Blog
BIOPHARMACEUTICAL
Pharmaceutical
Biomarkers
Sample Kits
Assays
Full Assay List
KCAS has established a wide range of assays in various biological matrices.
The methods tabulated below vary from Qualified to Fully Validated Methods.
For details, please contact us here.
PDF
Assay Search
Acetaminophen (APAP)
Matrix:
LLOQ:
0.1
Unit:
mcg/mL
Platform:
LC-MS/MS
Acetaminophen / Tramadol
Matrix:
LLOQ:
100 / 5
Unit:
ng/mL
Platform:
LC-MS/MS
Acid Glycoprotein, α1
Matrix:
Human Plasma
LLOQ:
3.5
Unit:
ng/mL
Platform:
ELISA/ECL
Adipenectin
Matrix:
Human Serum
LLOQ:
0.8
Unit:
ng/mL
Platform:
ELISA/ECL
Alkaline Hematin
Matrix:
LLOQ:
1.0 or 2.5 mL
Unit:
mL
Platform:
ALL (CD7, CD79b, CD117, CD19, CD10, CD4, CD8, CD3, CD5, CD45)
Matrix:
Whole Blood
LLOQ:
N/A
Unit:
% recovery & absolute counts
Platform:
Flow Cytometry
Allopurinol / Oxypurinol
Matrix:
Human Plasma
LLOQ:
50 / 100
Unit:
ng/mL
Platform:
LC-MS/MS
Alprazolam
Matrix:
Human Plasma
LLOQ:
0.5
Unit:
ng/mL
Platform:
LC-MS/MS
Alprazolam and a-Hydroxyalprazolam
Matrix:
Dog Plasma
LLOQ:
0.5
Unit:
ng/mL
Platform:
LC-MS/MS
Alprazolam and a-Hydroxyalprazolam
Matrix:
Human Plasma
LLOQ:
0.5
Unit:
ng/mL
Platform:
LC-MS/MS
Amikacin
Matrix:
Human Serum
LLOQ:
0.15
Unit:
mcg/mL
Platform:
LC-MS/MS
Amikacin
Matrix:
Human Urine
LLOQ:
0.5
Unit:
mcg/mL
Platform:
LC-MS/MS
Amiodarone / Desethylamiodarone
Matrix:
Human Plasma
LLOQ:
10
Unit:
ng/mL
Platform:
LC-MS/MS
Amitriptyline
Matrix:
Human Plasma
LLOQ:
200
Unit:
pg/mL
Platform:
LC-MS/MS
Amlodipine
Matrix:
Human Plasma
LLOQ:
50
Unit:
pg/mL
Platform:
LC-MS/MS
Amlodipine
Matrix:
Human Plasma
LLOQ:
0 / 10
Unit:
ng/mL
Platform:
LC-MS/MS
Amyloid Beta 38 (Ab-38)
Matrix:
Human CSF
LLOQ:
60
Unit:
pg/mL
Platform:
ECL
Amyloid Beta 40 (Ab-40)
Matrix:
Human CSF
LLOQ:
25
Unit:
pg/mL
Platform:
ECL
Amyloid Beta 42 (Ab-42)
Matrix:
Human CSF
LLOQ:
4
Unit:
pg/mL
Platform:
ECL
Aprepitant
Matrix:
Human Plasma
LLOQ:
10
Unit:
ng/mL
Platform:
LC-MS/MS
Atenolol
Matrix:
Human Plasma
LLOQ:
10
Unit:
ng/mL
Platform:
LC-MS/MS
Atenolol
Matrix:
Human Urine
LLOQ:
250
Unit:
ng/mL
Platform:
LC-MS/MS
Atomoxetine
Matrix:
Human Plasma
LLOQ:
10
Unit:
ng/mL
Platform:
LC-MS/MS
Atorvastatin / p- and o-Hydroxyatorvastatin
Matrix:
Human Plasma
LLOQ:
0.2 / 0.2 / 0.2
Unit:
ng/mL
Platform:
LC-MS/MS
Azacytidine, 5-
Matrix:
Human Plasma
LLOQ:
10
Unit:
ng/mL
Platform:
LC-MS/MS
Azithromycin
Matrix:
Human Plasma
LLOQ:
2
Unit:
ng/mL
Platform:
LC-MS/MS
B cells (IgD, CD21, CD19, CD27, CD24, CD38, IgM, CD45)
Matrix:
Whole Blood
LLOQ:
N/A
Unit:
% recovery & absolute counts
Platform:
Flow Cytometry
Benazepril / Benazeprilat
Matrix:
Human Plasma
LLOQ:
5 / 10
Unit:
ng/mL
Platform:
LC-MS/MS
Benazepril / Benazeprilat
Matrix:
Dog Plasma
LLOQ:
0.1 / 0.5
Unit:
ng/mL
Platform:
LC-MS/MS
Bicalutamide
Matrix:
Human Plasma
LLOQ:
2.5
Unit:
ng/mL
Platform:
LC-MS/MS
Brompheniramine
Matrix:
Human Plasma
LLOQ:
0.5
Unit:
ng/mL
Platform:
LC-MS/MS
Brompheniramine / Chlorpheniramine / Pseudeophedrine
Matrix:
Human Plasma
LLOQ:
0.5 / 0.5 / 5
Unit:
ng/mL
Platform:
LC-MS/MS
Bucladesine
Matrix:
Human Plasma
LLOQ:
1
Unit:
ng/mL
Platform:
LC-MS/MS
Buprenorphine
Matrix:
Dog Plasma
LLOQ:
0.1
Unit:
ng/mL
Platform:
LC-MS/MS
Buprenorphine / Norbuprenorphine
Matrix:
Cat Plasma
LLOQ:
0.5
Unit:
ng/mL
Platform:
LC-MS/MS
Buprenorphine / Norbuprenorphine
Matrix:
Human Plasma
LLOQ:
0.5
Unit:
ng/mL
Platform:
LC-MS/MS
Buprenorphine / Norbuprenorphine
Matrix:
Dog Plasma
LLOQ:
100
Unit:
pg/mL
Platform:
LC-MS/MS
Buprenorphine / Norbuprenorphine
Matrix:
Rabbit Plasma
LLOQ:
50
Unit:
pg/mL
Platform:
LC-MS/MS
Buspirone / 1-PP
Matrix:
Dog Plasma
LLOQ:
100
Unit:
pg/mL
Platform:
LC-MS/MS
Buspirone / 1-PP
Matrix:
Human Plasma
LLOQ:
100
Unit:
pg/mL
Platform:
LC-MS/MS
Butorphanol
Matrix:
Human Plasma
LLOQ:
20
Unit:
pg/mL
Platform:
LC-MS/MS
Canrenone
Matrix:
Human Plasma
LLOQ:
2
Unit:
ng/mL
Platform:
LC-MS/MS
Canrenone
Matrix:
Human Urine
LLOQ:
20
Unit:
ng/mL
Platform:
LC-MS/MS
Captisol
Matrix:
Human Plasma
LLOQ:
5
Unit:
mcg/mL
Platform:
LC-MS/MS
Carisbamate
Matrix:
Human Plasma
LLOQ:
5
Unit:
ng/mL
Platform:
LC-MS/MS
Cetirizine
Matrix:
Human Plasma
LLOQ:
2
Unit:
ng/mL
Platform:
LC-MS/MS
Chlorpheniramine
Matrix:
Human Plasma
LLOQ:
0.5
Unit:
ng/mL
Platform:
LC-MS/MS
Chlorzoxazone
Matrix:
Human Plasma
LLOQ:
20
Unit:
ng/mL
Platform:
LC-MS/MS
Ciprofloxacin
Matrix:
Human Serum
LLOQ:
10
Unit:
ng/mL
Platform:
LC-MS/MS
Ciprofloxacin
Matrix:
Human Plasma
LLOQ:
10
Unit:
ng/mL
Platform:
LC-MS/MS
Citric Acid
Matrix:
Human Urine
LLOQ:
50
Unit:
ng/mL
Platform:
LC-MS/MS
Clarithromycin
Matrix:
Human Plasma
LLOQ:
10
Unit:
ng/mL
Platform:
LC-MS/MS
CLL (KAPPA, LAMBDA, CD117, CD19, CD10, CD20, CD23, CD43, CD5, CD45)
Matrix:
Whole Blood
LLOQ:
N/A
Unit:
% recovery & absolute counts
Platform:
Flow Cytometry
Clonazepam
Matrix:
Human Plasma
LLOQ:
100
Unit:
pg/mL
Platform:
LC-MS/MS
Clonazepam / 7-Hydroxyclonazepam
Matrix:
Human Plasma
LLOQ:
0.1 / 0.2
Unit:
pg/mL
Platform:
LC-MS/MS
Clonidine
Matrix:
Human Plasma
LLOQ:
10
Unit:
pg/mL
Platform:
LC-MS/MS
Clotrimazole / Ketoconazole
Matrix:
Human Plasma
LLOQ:
5 / 50
Unit:
ng/mL
Platform:
LC-MS/MS
Cluster of Differentiation 14 (CD-14)
Matrix:
Human Plasma
LLOQ:
100
Unit:
pg/mL
Platform:
ELISA/ECL
Codeine
Matrix:
Human Plasma
LLOQ:
1
Unit:
ng/mL
Platform:
LC-MS/MS
Cordycepin
Matrix:
Human Plasma
LLOQ:
1
Unit:
ng/mL
Platform:
LC-MS/MS
Cortisol
Matrix:
Human Plasma
LLOQ:
40.4
Unit:
ng/mL
Platform:
LC-MS/MS
Cromolyn
Matrix:
Human Plasma
LLOQ:
10
Unit:
ng/mL
Platform:
LC-MS/MS
Cromolyn
Matrix:
Human CSF
LLOQ:
0.1
Unit:
ng/mL
Platform:
LC-MS/MS
Cyclobenzaprine
Matrix:
Dog Plasma
LLOQ:
0.1
Unit:
ng/mL
Platform:
LC-MS/MS
Cyclobenzaprine
Matrix:
Human Plasma
LLOQ:
0.1
Unit:
ng/mL
Platform:
LC-MS/MS
Cytarabine (Ara-C)
Matrix:
Human Plasma
LLOQ:
20
Unit:
ng/mL
Platform:
LC-MS/MS
DCs (CD16, LINEAGE, CD1c, CD11c, Clee9A, CD123, HLA-DR, CD45)
Matrix:
Whole Blood
LLOQ:
N/A
Unit:
% recovery & absolute counts
Platform:
Flow Cytometry
Deoxycholic Acid
Matrix:
Human Plasma
LLOQ:
10
Unit:
ng/mL
Platform:
LC-MS/MS
Dexamethasone
Matrix:
Human Plasma
LLOQ:
0.25
Unit:
ng/mL
Platform:
LC-MS/MS
Dextromethorphan
Matrix:
Human Plasma
LLOQ:
50
Unit:
pg/mL
Platform:
LC-MS/MS
Diclofenac
Matrix:
Human Plasma
LLOQ:
5
Unit:
ng/mL
Platform:
LC-MS/MS
Digoxin
Matrix:
Human Plasma
LLOQ:
0.1
Unit:
ng/mL
Platform:
LC-MS/MS
Diltiazem / N-Desmethyldiltiazem / Desacetyldiltiazem
Matrix:
Human Plasma
LLOQ:
4 / 2 / 1
Unit:
ng/mL
Platform:
LC-MS/MS
Diphenydramine
Matrix:
Human Plasma
LLOQ:
1
Unit:
ng/mL
Platform:
LC-MS/MS
Dipyridamole
Matrix:
Human Plasma
LLOQ:
50
Unit:
ng/mL
Platform:
LC-MS/MS
Doxepin / Nordoxepin
Matrix:
Human Urine
LLOQ:
0.25 / 0.20
Unit:
ng/mL
Platform:
LC-MS/MS
Doxorubicin
Matrix:
Human Plasma
LLOQ:
100
Unit:
ng/mL
Platform:
LC-MS/MS
Doxorubicin
Matrix:
Human Urine
LLOQ:
1.5
Unit:
ng/mL
Platform:
LC-MS/MS
Doxorubicin/Doxorubicinol
Matrix:
Human Plasma
LLOQ:
0.5 / 0.5
Unit:
ng/mL
Platform:
LC-MS/MS
DTC panel 1 (CD16, CD56, CD19, CD25, CD39, CD14, CD4, CD8, CD3, HLA-A2, CD45)
Matrix:
Whole Blood
LLOQ:
N/A
Unit:
% recovery & absolute counts
Platform:
Flow Cytometry
DTC panel 2 (CD47, CD133, CD326, 7AAD, CD324, CD274, CD44, HLA-A2, CD45)
Matrix:
Whole Blood
LLOQ:
N/A
Unit:
% recovery & absolute counts
Platform:
Flow Cytometry
Efavirenz
Matrix:
Human Plasma
LLOQ:
50
Unit:
ng/mL
Platform:
LC-MS/MS
Enalapril & Enalaprilat
Matrix:
Human Plasma
LLOQ:
250
Unit:
pg/mL
Platform:
LC-MS/MS
Eotaxin
Matrix:
Human Plasma
LLOQ:
5.86
Unit:
pg/mL
Platform:
ELISA/ECL
Eotaxin-3
Matrix:
Human Plasma
LLOQ:
4.85
Unit:
pg/mL
Platform:
ELISA/ECL
Esomeprazole
Matrix:
Human Plasma
LLOQ:
0.25
Unit:
ng/mL
Platform:
LC-MS/MS
Ethambutol
Matrix:
Human DBS
LLOQ:
100
Unit:
ng/mL
Platform:
LC-MS/MS
Famotidine
Matrix:
Human Plasma
LLOQ:
2
Unit:
ng/mL
Platform:
LC-MS/MS
Famotidine
Matrix:
Human Urine
LLOQ:
2
Unit:
ng/mL
Platform:
LC-MS/MS
Felodipine
Matrix:
Human Plasma
LLOQ:
25
Unit:
pg/mL
Platform:
LC-MS/MS
Fenofibric Acid
Matrix:
Human Plasma
LLOQ:
25
Unit:
ng/mL
Platform:
LC-MS/MS
Fexofenadine
Matrix:
Human Plasma
LLOQ:
1
Unit:
ng/mL
Platform:
LC-MS/MS
Fexofenadine
Matrix:
Mouse Plasma
LLOQ:
25
Unit:
ng/mL
Platform:
LC-MS/MS
Fexofenadine
Matrix:
Rabbit Plasma
LLOQ:
25
Unit:
ng/mL
Platform:
LC-MS/MS
Fexofenadine
Matrix:
Rat Plasma
LLOQ:
25
Unit:
ng/mL
Platform:
LC-MS/MS
Flavoxate / MFCA metabolite
Matrix:
Human Plasma
LLOQ:
0.1
Unit:
ng/mL
Platform:
LC-MS/MS
Furosemide
Matrix:
Human Plasma
LLOQ:
50
Unit:
ng/mL
Platform:
LC-MS/MS
Furosemide
Matrix:
Human Urine
LLOQ:
50
Unit:
ng/mL
Platform:
LC-MS/MS
Ghrelin
Matrix:
Human Serum
LLOQ:
94
Unit:
pg/mL
Platform:
ELISA/ECL
Ghrelin Active
Matrix:
Human Plasma
LLOQ:
100
Unit:
pg/mL
Platform:
ELISA/ECL
Ghrelin Total
Matrix:
Human Plasma
LLOQ:
200
Unit:
pg/mL
Platform:
ELISA/ECL
Granisetron
Matrix:
Dog Plasma
LLOQ:
100
Unit:
pg/mL
Platform:
LC-MS/MS
Granulocyte Macrophage- Colony Stimulating Factor (GM-CSF)
Matrix:
Human Plasma
LLOQ:
0.243
Unit:
pg/mL
Platform:
ELISA/ECL
Guaifenesin
Matrix:
Human Plasma
LLOQ:
2.5
Unit:
ng/mL
Platform:
LC-MS/MS
Guaifenesin / Naproxen
Matrix:
Human Plasma
LLOQ:
10 / 250
Unit:
ng/mL
Platform:
LC-MS/MS
Haloperidol
Matrix:
Human Plasma
LLOQ:
25
Unit:
pg/mL
Platform:
LC-MS/MS
Hepatocyte Growth Factor (HGF)
Matrix:
Human Plasma
LLOQ:
400
Unit:
pg/mL
Platform:
ELISA/ECL
Heptazyme Antibodies
Matrix:
Monkey Serum
LLOQ:
1:25,600
Unit:
titer
Platform:
ELISA/ECL
Histone DeAc (fixable L/D, H3 K27Ac, CD19, CD56, CD114, CD4, CD8, CD3, HLA-DR,DP,DQ, CD45)
Matrix:
Whole Blood
LLOQ:
N/A
Unit:
% recovery & absolute counts
Platform:
Flow Cytometry
Homocysteine
Matrix:
Rat Plasma
LLOQ:
5
Unit:
mcg/mL
Platform:
LC-MS/MS
Homocysteine
Matrix:
Dog Plasma
LLOQ:
5
Unit:
mcg/mL
Platform:
LC-MS/MS
Hydrocodone
Matrix:
Human Plasma
LLOQ:
0.25
Unit:
ng/mL
Platform:
LC-MS/MS
Hydromorphone
Matrix:
Dog Plasma
LLOQ:
20
Unit:
pg/mL
Platform:
LC-MS/MS
Hydromorphone
Matrix:
Human Plasma
LLOQ:
20
Unit:
pg/mL
Platform:
LC-MS/MS
Hydromorphone
Matrix:
Dog Serum
LLOQ:
20
Unit:
pg/mL
Platform:
LC-MS/MS
Hydroxymephenytoin, (R)-4- / Hydroxymephenytoin, (S)-4-
Matrix:
Human Plasma
LLOQ:
10
Unit:
ng/mL
Platform:
LC-MS/MS
Hydroxymephenytoin, (R)-4- / Hydroxymephenytoin, (S)-4-
Matrix:
Human Saliva
LLOQ:
10
Unit:
ng/mL
Platform:
LC-MS/MS
Hydroxymephenytoin, (R)-4- / Hydroxymephenytoin, (S)-4-
Matrix:
Human Urine
LLOQ:
0.1
Unit:
mcg/mL
Platform:
LC-MS/MS
Hydroxymidazolam, a- / Hydoxymidazolam, 4-
Matrix:
Dog Plasma
LLOQ:
2 / 2
Unit:
ng/mL
Platform:
LC-MS/MS
Hydroxymidazolam, a- / Hydoxymidazolam, 4-
Matrix:
Rat Plasma
LLOQ:
2 / 2
Unit:
ng/mL
Platform:
LC-MS/MS
Ibuprofen
Matrix:
Human Plasma
LLOQ:
0.25
Unit:
mcg/mL
Platform:
LC-MS/MS
Ibuprofen
Matrix:
Human CSF
LLOQ:
0.3
Unit:
ng/mL
Platform:
LC-MS/MS
Ibuprofen
Matrix:
Human Plasma
LLOQ:
25
Unit:
ng/mL
Platform:
LC-MS/MS
Imipramine / Desipramine
Matrix:
Human Plasma
LLOQ:
0.1
Unit:
ng/mL
Platform:
LC-MS/MS
Indomethacin
Matrix:
Human Plasma
LLOQ:
10
Unit:
ng/mL
Platform:
LC-MS/MS
Interferon alpha
Matrix:
Human Serum
LLOQ:
10
Unit:
pg/mL
Platform:
ELISA/ECL
Interferon b1 (IFN-b1)
Matrix:
Human Plasma
LLOQ:
2
Unit:
pg/mL
Platform:
ELISA/ECL
Interferon g – inducible Protien -10 (IP-10)
Matrix:
Human Plasma
LLOQ:
150
Unit:
pg/mL
Platform:
ELISA/ECL
Interferon-g (IFN-g)
Matrix:
Human Plasma
LLOQ:
15
Unit:
pg/mL
Platform:
ELISA/ECL
Interferon-g (INF-g)
Matrix:
Human Plasma
LLOQ:
1.33
Unit:
pg/mL
Platform:
ELISA/ECL
Interleukin- 10 (IL-10)
Matrix:
Human Plasma
LLOQ:
0.309
Unit:
pg/mL
Platform:
ELISA/ECL
Interleukin- 12 (IL-12/IL-23p40)
Matrix:
Human Plasma
LLOQ:
0.786
Unit:
pg/mL
Platform:
ELISA/ECL
Interleukin- 13 (IL-13)
Matrix:
Human Plasma
LLOQ:
2.45
Unit:
pg/mL
Platform:
ELISA/ECL
Interleukin- 15 (IL-15)
Matrix:
Human Plasma
LLOQ:
0.19
Unit:
pg/mL
Platform:
ELISA/ECL
Interleukin- 16 (IL-16)
Matrix:
Human Plasma
LLOQ:
2.47
Unit:
pg/mL
Platform:
ELISA/ECL
Interleukin- 2 (IL-2)
Matrix:
Human Plasma
LLOQ:
0.315
Unit:
pg/mL
Platform:
ELISA/ECL
Interleukin- 5 (IL-5)
Matrix:
Human Plasma
LLOQ:
3.56
Unit:
pg/mL
Platform:
ELISA/ECL
Interleukin- 6 (IL-6)
Matrix:
Human Plasma
LLOQ:
0.626
Unit:
pg/mL
Platform:
ELISA/ECL
Interleukin- 7 (IL-7)
Matrix:
Human Plasma
LLOQ:
0.205
Unit:
pg/mL
Platform:
ELISA/ECL
Interleukin- 8 (IL-8(HA))
Matrix:
Human Plasma
LLOQ:
1185.9
Unit:
pg/mL
Platform:
ELISA/ECL
Interleukin- 8 (IL-8)
Matrix:
Human Plasma
LLOQ:
0.488
Unit:
pg/mL
Platform:
ELISA/ECL
Interleukin-10 (IL-10)
Matrix:
Human Plasma
LLOQ:
0.5
Unit:
pg/mL
Platform:
ELISA/ECL
Interleukin-10 (IL-10)
Matrix:
Rat Plasma
LLOQ:
20
Unit:
pg/mL
Platform:
ELISA/ECL
Interleukin-10 (IL-10)
Matrix:
Rat Tissue
LLOQ:
20
Unit:
pg/mL
Platform:
ELISA/ECL
Interleukin-12 (IL-12p70)
Matrix:
Human Plasma
LLOQ:
0.401
Unit:
pg/mL
Platform:
ELISA/ECL
Interleukin-17A (IL-17A)
Matrix:
Human Plasma
LLOQ:
1.47
Unit:
pg/mL
Platform:
ELISA/ECL
Interleukin-1a (IL-1a)
Matrix:
Human Plasma
LLOQ:
0.396
Unit:
pg/mL
Platform:
ELISA/ECL
Interleukin-1b (IL-1b)
Matrix:
Human Plasma
LLOQ:
0.46
Unit:
pg/mL
Platform:
ELISA/ECL
Interleukin-4 (IL-4)
Matrix:
Human Plasma
LLOQ:
0.064
Unit:
pg/mL
Platform:
ELISA/ECL
Intracellular (IFN gamma, TNF alpha, IL-2, CD8, CD3, CD4)
Matrix:
Whole Blood
LLOQ:
N/A
Unit:
% recovery & absolute counts
Platform:
Flow Cytometry
Isotretinoin / 4-Oxo-Isotretinoin
Matrix:
Human Plasma
LLOQ:
10
Unit:
ng/mL
Platform:
LC-MS/MS
Isradapine
Matrix:
Human Plasma
LLOQ:
100
Unit:
pg/mL
Platform:
LC-MS/MS
Ketoconazole / Clotrimazole
Matrix:
Human Plasma
LLOQ:
50 / 5
Unit:
ng/mL
Platform:
LC-MS/MS
Ketoprofen
Matrix:
Human Plasma
LLOQ:
1
Unit:
ng/mL
Platform:
LC-MS/MS
Levofloxacin
Matrix:
Rabbit Plasma
LLOQ:
0.2
Unit:
mcg/mL
Platform:
LC-MS/MS
Lidocaine
Matrix:
Dog Plasma
LLOQ:
0.1
Unit:
ng/mL
Platform:
LC-MS/MS
Lidocaine
Matrix:
Dog Urine
LLOQ:
0.1
Unit:
ng/mL
Platform:
LC-MS/MS
Lidocaine
Matrix:
Dog Tissue
LLOQ:
10
Unit:
ng/g
Platform:
LC-MS/MS
Lidocaine
Matrix:
Rat Plasma
LLOQ:
0.5
Unit:
ng/mL
Platform:
LC-MS/MS
Lorazepam
Matrix:
Human Plasma
LLOQ:
1
Unit:
ng/mL
Platform:
LC-MS/MS
Losartan / Carboxylosartan
Matrix:
Human Plasma
LLOQ:
2 / 2
Unit:
ng/mL
Platform:
LC-MS/MS
Macrophage Inflammatory Protein (MIP-1a)
Matrix:
Human Plasma
LLOQ:
3.68
Unit:
pg/mL
Platform:
ELISA/ECL
Macrophage Inflammatory Protein (MIP-1b)
Matrix:
Human Plasma
LLOQ:
0.99
Unit:
pg/mL
Platform:
ELISA/ECL
Macrophage-derived chemokin (MDC)
Matrix:
Human Plasma
LLOQ:
10.4
Unit:
pg/mL
Platform:
ELISA/ECL
Meloxicam
Matrix:
Human Plasma
LLOQ:
10
Unit:
ng/mL
Platform:
LC-MS/MS
Memantine
Matrix:
Human Plasma
LLOQ:
0.5
Unit:
ng/mL
Platform:
LC-MS/MS
Memantine N-Glucuronide
Matrix:
Human Plasma
LLOQ:
0.2
Unit:
ng/mL
Platform:
LC-MS/MS
Mephenytoin, (R)- / Mephenytoin, (S)-
Matrix:
Human Plasma
LLOQ:
10
Unit:
ng/mL
Platform:
LC-MS/MS
Mephenytoin, (R)- / Mephenytoin, (S)-
Matrix:
Human Saliva
LLOQ:
10
Unit:
ng/mL
Platform:
LC-MS/MS
Mephenytoin, (R)- / Mephenytoin, (S)-
Matrix:
Human Urine
LLOQ:
0.1
Unit:
mcg/mL
Platform:
LC-MS/MS
Mephenytoin, (R)- / Mephenytoin, (S)-
Matrix:
Human Urine
LLOQ:
0.1
Unit:
mcg/mL
Platform:
LC-MS/MS
Mercaptopurine, 6- / 6-Thiouric Acid
Matrix:
Human Plasma
LLOQ:
2 / 20
Unit:
ng/mL
Platform:
LC-MS/MS
Mercaptopurine, 6- / 6-Thiouric Acid
Matrix:
Human Urine
LLOQ:
6 / 60
Unit:
ng/mL
Platform:
LC-MS/MS
Metformin
Matrix:
Human Plasma
LLOQ:
20
Unit:
ng/mL
Platform:
LC-MS/MS
Methylnicotinamide
Matrix:
Human Plasma
LLOQ:
10
Unit:
ng/mL
Platform:
LC-MS/MS
Methylnicotinamide
Matrix:
Human Plasma
LLOQ:
10
Unit:
ng/mL
Platform:
LC-MS/MS
Methylphenidate
Matrix:
Human Plasma
LLOQ:
100
Unit:
pg/ml
Platform:
LC-MS/MS
Methylprednisolone
Matrix:
Human Plasma
LLOQ:
2.5
Unit:
ng/mL
Platform:
LC-MS/MS
Metoprolol
Matrix:
Human Plasma
LLOQ:
1
Unit:
ng/mL
Platform:
LC-MS/MS
Midazolam / 1-Hydroxymidazolam / 4-Hydroxymidazolam
Matrix:
Human Urine
LLOQ:
10 / 2 / 2
Unit:
ng/mL
Platform:
LC-MS/MS
Midazolam / a-Hydroxymidazolam
Matrix:
Human Urine
LLOQ:
20 / 0.5
Unit:
ng/mL
Platform:
LC-MS/MS
MM1 (KAPPA, LAMBDA, CD48, CD56, CD117, CD138, CD38, CD33, CD19, CD45)
Matrix:
Whole Blood
LLOQ:
N/A
Unit:
% recovery & absolute counts
Platform:
Flow Cytometry
MM2 (CD9, CD13, CD10, CD3, CD117, CD138, CD38, CD33, CD19, CD45)
Matrix:
Whole Blood
LLOQ:
N/A
Unit:
% recovery & absolute counts
Platform:
Flow Cytometry
Molindone
Matrix:
Human Plasma
LLOQ:
0.5
Unit:
ng/mL
Platform:
LC-MS/MS
Monocyte Chemotactic Protein 1 (MCP-1)
Matrix:
Human Plasma
LLOQ:
0.109
Unit:
pg/mL
Platform:
ELISA/ECL
Monocyte Chemotactic Protein 1 (MCP-1)
Matrix:
Human Plasma
LLOQ:
30
Unit:
pg/mL
Platform:
ELISA/ECL
Monocyte Chemotactic Protein 3 (MCP-3)
Matrix:
Human Plasma
LLOQ:
15
Unit:
pg/mL
Platform:
ELISA/ECL
Monocyte Chemotactic Protein 4 (MCP-4)
Matrix:
Human Plasma
LLOQ:
9.41
Unit:
pg/mL
Platform:
ELISA/ECL
Morphine / Morphine-3-Glucuronide / Morpine-6-Glucuronide
Matrix:
Dog Plasma
LLOQ:
0.5 / 5 / 2
Unit:
ng/mL
Platform:
LC-MS/MS
Morphine / Morphine-3-Glucuronide / Morpine-6-Glucuronide
Matrix:
Human Plasma
LLOQ:
0.5 / 5 / 2
Unit:
ng/mL
Platform:
LC-MS/MS
Morphine / Morphine-3-Glucuronide / Morpine-6-Glucuronide
Matrix:
Ovine Plasma
LLOQ:
0.5 / 5 / 2
Unit:
ng/mL
Platform:
LC-MS/MS
Moxifloxacin
Matrix:
Human DBS
LLOQ:
100
Unit:
ng/mL
Platform:
LC-MS/MS
Moxifloxacin
Matrix:
Human Plasma
LLOQ:
20
Unit:
ng/mL
Platform:
LC-MS/MS
Niacin (Nicotinic Acid) / Nicotinuric Acid
Matrix:
Human Urine
LLOQ:
25
Unit:
ng/mL
Platform:
LC-MS/MS
Nifedipine / NPO
Matrix:
Human Plasma
LLOQ:
1
Unit:
ng/mL
Platform:
LC-MS/MS
Noroxycodone
Matrix:
Human Plasma
LLOQ:
0.25
Unit:
ng/mL
Platform:
LC-MS/MS
Olanzapine
Matrix:
Human Plasma
LLOQ:
0.1
Unit:
ng/mL
Platform:
LC-MS/MS
Omeprazole
Matrix:
Human Plasma
LLOQ:
0.25
Unit:
ng/mL
Platform:
LC-MS/MS
Ondansetron
Matrix:
Human Plasma
LLOQ:
0.5
Unit:
ng/mL
Platform:
LC-MS/MS
Oxandrolone
Matrix:
Human Plasma
LLOQ:
0.25
Unit:
ng/mL
Platform:
LC-MS/MS
Oxybutynin / N-Desethyloxybutynin
Matrix:
Human Plasma
LLOQ:
0.0500 / 0.25
Unit:
ng/mL
Platform:
LC-MS/MS
Oxycodone / Noroxycodcone / Oxymorphone
Matrix:
Human Plasma
LLOQ:
0.25
Unit:
ng/mL
Platform:
LC-MS/MS
Oxymorphone
Matrix:
Human Plasma
LLOQ:
0.25
Unit:
ng/mL
Platform:
LC-MS/MS
Paclitaxel
Matrix:
Human Plasma
LLOQ:
10
Unit:
ng/mL
Platform:
LC-MS/MS
Paclitaxel
Matrix:
Human Urine
LLOQ:
5
Unit:
ng/mL
Platform:
LC-MS/MS
Pantoprazole
Matrix:
Human Plasma
LLOQ:
10
Unit:
ng/mL
Platform:
LC-MS/MS
Paroxetine
Matrix:
Human Plasma
LLOQ:
100
Unit:
pg/mL
Platform:
LC-MS/MS
Pentazocine
Matrix:
Human Plasma
LLOQ:
1
Unit:
ng/mL
Platform:
LC-MS/MS
Phenylephrine
Matrix:
Human Urine
LLOQ:
5
Unit:
ng/mL
Platform:
LC-MS/MS
Phenylephrine
Matrix:
Human Plasma
LLOQ:
0.5
Unit:
ng/mL
Platform:
LC-MS/MS
Primidone
Matrix:
Human Plasma
LLOQ:
25
Unit:
ng/mL
Platform:
LC-MS/MS
Propafenone / N-Despropylpropafenone- / 5-Hydroxypropafenone
Matrix:
Human Plasma
LLOQ:
250
Unit:
pg/mL
Platform:
LC-MS/MS
Propoxyphene/Norpropoxyphene
Matrix:
Human Plasma
LLOQ:
1
Unit:
ng/mL
Platform:
LC-MS/MS
Pseudoephedrine
Matrix:
Human Plasma
LLOQ:
5
Unit:
ng/mL
Platform:
LC-MS/MS
Resistin
Matrix:
Human Plasma
LLOQ:
160
Unit:
ng/mL
Platform:
ELISA/ECL
Ribavirin
Matrix:
Human Plasma
LLOQ:
5
Unit:
ng/mL
Platform:
LC-MS/MS
Rifampin
Matrix:
Human DBS
LLOQ:
200
Unit:
ng/mL
Platform:
LC-MS/MS
Risperidone
Matrix:
Human Plasma
LLOQ:
0.1
Unit:
ng/mL
Platform:
LC-MS/MS
Ropinirole
Matrix:
Human Plasma
LLOQ:
20
Unit:
pg/mL
Platform:
LC-MS/MS
Ropinirole
Matrix:
Mini-Pig Plasma
LLOQ:
20
Unit:
pg/mL
Platform:
LC-MS/MS
Rosuvastatin
Matrix:
Human Plasma
LLOQ:
0.2
Unit:
ng/mL
Platform:
LC-MS/MS
Simvastatin / Simvastatin Hydroxy Acid
Matrix:
Human Plasma
LLOQ:
0.5 / 0.5
Unit:
ng/mL
Platform:
LC-MS/MS
Spironolactone
Matrix:
Human Plasma
LLOQ:
2
Unit:
ng/mL
Platform:
LC-MS/MS
Sumatriptan
Matrix:
Human Plasma
LLOQ:
0.5
Unit:
ng/mL
Platform:
LC-MS/MS
T reg intranuclear (CD45RA, CD25, CD39, CD4, FoxP3, CD3, Helios, CD45)
Matrix:
Whole Blood
LLOQ:
N/A
Unit:
% recovery & absolute counts
Platform:
Flow Cytometry
T subsets (CD45RA, CD197/CCR7, CD28, CD279/PD1, CD27, CD4, CD8, CD3, CD57, CD45)
Matrix:
Whole Blood
LLOQ:
N/A
Unit:
% recovery & absolute counts
Platform:
Flow Cytometry
Tacrolimus
Matrix:
Human Whole Blood
LLOQ:
0.5
Unit:
ng/mL
Platform:
LC-MS/MS
Tacrolimus
Matrix:
Rat DBS
LLOQ:
5
Unit:
ng/mL
Platform:
LC-MS/MS
Tacrolimus
Matrix:
Dog Whole Blood
LLOQ:
0.1
Unit:
ng/mL
Platform:
LC-MS/MS
TBNK (CD16, CD56, CD19, CD25, CD14, CD4, CD8, CD3, HLA-DR, CD45)
Matrix:
Whole Blood
LLOQ:
N/A
Unit:
% recovery & absolute counts
Platform:
Flow Cytometry
TCR (TCR gamma-delta, TCR alpha-beta, HLA-DR, TCR Vdelta1, CD4, CD8, CD3, TCR Vdelta2, CD45)
Matrix:
Whole Blood
LLOQ:
N/A
Unit:
% recovery & absolute counts
Platform:
Flow Cytometry
Temazepam
Matrix:
Human Plasma
LLOQ:
20
Unit:
ng/mL
Platform:
LC-MS/MS
Tenofovir
Matrix:
Human Plasma
LLOQ:
10
Unit:
ng/mL
Platform:
LC-MS/MS
Terbinafine
Matrix:
Human Nail
LLOQ:
5
Unit:
pg/mg
Platform:
LC-MS/MS
Terbinafine / N-Desmethylterbinafine
Matrix:
Human Plasma
LLOQ:
40
Unit:
pg/mL
Platform:
LC-MS/MS
Thymus Activation-Regulated Chemokine (TARC)
Matrix:
Human Plasma
LLOQ:
0.366
Unit:
pg/mL
Platform:
ELISA/ECL
Tizanidine
Matrix:
Human Plasma
LLOQ:
100
Unit:
pg/mL
Platform:
LC-MS/MS
Total Tau
Matrix:
Human CSF
LLOQ:
30
Unit:
pg/mL
Platform:
ELISA/ECL
Tramadol
Matrix:
Dog Plasma
LLOQ:
2
Unit:
ng/mL
Platform:
LC-MS/MS
Tramadol / Acetaminophen
Matrix:
Human Plasma
LLOQ:
5 / 100
Unit:
ng/mL
Platform:
LC-MS/MS
Tretinoin / Isotretinoin
Matrix:
Human Plasma
LLOQ:
43383
Unit:
ng/mL
Platform:
LC-MS/MS
Triamcinolone
Matrix:
Human Plasma
LLOQ:
20
Unit:
pg/mL
Platform:
LC-MS/MS
Triamterene
Matrix:
Human Plasma
LLOQ:
2
Unit:
ng/mL
Platform:
LC-MS/MS
Tumor Necrosis Factor (TNF-a)
Matrix:
Human Plasma
LLOQ:
0.31
Unit:
pg/mL
Platform:
ELISA/ECL
Tumor Necrosis Factor (TNF-b)
Matrix:
Human Plasma
LLOQ:
0.154
Unit:
pg/mL
Platform:
ELISA/ECL
Tyramine
Matrix:
Human Plasma
LLOQ:
1
Unit:
ng/mL
Platform:
LC-MS/MS
Valproic Acid
Matrix:
Human Plasma
LLOQ:
0.5
Unit:
mcg/mL
Platform:
LC-MS/MS
Vascular Endothelial Growth Factor (VEGF)
Matrix:
Human Plasma
LLOQ:
3.98
Unit:
pg/mL
Platform:
ELISA/ECL
Venlafaxine / O-Desmethylvenlafaxine
Matrix:
Human Plasma
LLOQ:
2.5
Unit:
ng/mL
Platform:
LC-MS/MS
Vitamin B6
Matrix:
Human Plasma
LLOQ:
50
Unit:
ng/mL
Platform:
LC-MS/MS
Zolmitriptan / N-Desmethylzolmitriptan
Matrix:
Human Plasma
LLOQ:
0.1 / 0.1
Unit:
ng/mL
Platform:
LC-MS/MS
Zolpidem
Matrix:
Human Plasma
LLOQ:
0.5
Unit:
ng/mL
Platform:
LC-MS/MS
/* ----------------------------------------- */ /* View slug: assay-view - start */ /* ----------------------------------------- */ .serviceform {padding: 30px 0; font-size:1.4em;} .servicesearch {font-size: 1.2em; padding: 5px 15px; border-radius: 18px; border: solid 1px #b7b7b7;margin: 4px 0 8px 0;} .wpv-submit-trigger {font-size: 1em; padding: 5px 10px; border-radius: 5px; border: solid 1px #b7b7b7; cursor: pointer;} .wpv-reset-trigger {font-size: 1em; padding: 5px 10px; border-radius: 5px; border: solid 1px #b7b7b7; cursor: pointer;} .wpv-submit-trigger:hover, .wpv-reset-trigger:hover {background: #f7f7f7; -webkit-transition: all .3s ease-in-out; transition-property: all; transition-duration: 0.3s; transition-timing-function: ease-in-out; transition-delay: 0s;} @media only screen and (max-width: 768px){ .servicesearch {width:100%} } .assaytitle {padding: 5px 0 5px 15px;} .assaytitle h1 {color: #00659b; font-weight: 500;font-size:1.3em; } .assaytitle a {color: #00659b; } .assaydetail {font-size:1.1em; padding: 2px 0 2px 25px; color:#fff;} .assaydetail a {color:#fff;font-weight: 600; } ul { display: inline-block; list-style-type: none; } /* ----------------------------------------- */ /* View slug: assay-view - end */ /* ----------------------------------------- */
